Tech Company Inital Public Offerings
Tesaro IPO
Headquartered in Waltham, Tesaro is now a public company.
Transaction Overview
Company Name
Announced On
6/29/2012
Transaction Type
IPO
Amount
$81,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1000 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
TESARO (NASDAQ: TSRO) is an oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lonnie Moulder
Chief Financial Officer
Timothy Pearson
Chief Medical Officer
Martin Huber
President
Mary Hedley
Vice President
Orlando Oliveira
VP - Bus. Development
Grant Bogle
VP - Bus. Development
Allene Diaz
VP - General Counsel
Joseph Farmer
VP - Human Resources
Michelle Graham
VP - Operations
William Aitchison
VP - Regulatory Affairs
Jennifer Jackson
Browse more venture capital transactions:
Prev: 6/29/2012: Pact venture capital transaction
Next: 6/29/2012: IlluminOss Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs